PET-based technique can monitor engineered T cells during immunotherapy

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers at the Technical University of Munich (TUM) have developed a method for tracking these cells in the body. This new approach could deepen our understanding of cellular therapies and help make future treatments safer.

Leave A Comment

Your email address will not be published. Required fields are marked *